Switching Language

Please note that your current login session is only valid on the English site (letpub.com). You will not be signed in on other language versions of the site. If you wish to place an order, please return to the English site.

    Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector


New Free Tool: Verity — Pre-Submission Manuscript Check
Automatically checks your manuscript across 34 criteria including structure, metadata, disclosures, and language issues before you submit to your target journal.
Try for Free →
  
  
-

Journal for ImmunoTherapy of Cancer


👁  148461 Views

 296 Reviews  

 Open Access      SCIE      Official Website     Submission Website
 

*Average Peer Review
18 Weeks
*Competitiveness
CiteScore
17.8
CiteScore Rank
Subject Area Rank Percentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology		 13 / 321
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Oncology		 27 / 415
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine		 12 / 177
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology and Allergy		 17 / 231
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology		 19 / 240
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Cancer Research		 19 / 233
Link to PubMed Central (PMC)
https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2051-1426%5BISSN%5D

Indexing (SCI collection)
Science Citation Index Expanded (SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)

Country/Area of Publication
UNITED STATES
Publication Frequency
Publisher
BMJ PUBLISHING GROUP

ISSN
2051-1426
E-ISSN
2051-1426
Year Publication Started
2013

Self-citation (2024-2025)
2.80%
Annual Article Volume
422
Gold OA Percentage
99.56%

Open Access Info
APC APC Waiver Other Charges
Yes: Check details
( USD3180; )		Yes: Check detailsNo
Journal Aim & Scope
Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.

Web of Science Quartiles
WOS Quartile: Q1

Quartiles By JIFCollectionQuartileRankPercentage
Category: IMMUNOLOGYSCIEQ112/183
Category: ONCOLOGYSCIEQ127/328
Quartiles By JCICollectionQuartileRankPercentage
Category: IMMUNOLOGYSCIEQ111/183
Category: ONCOLOGYSCIEQ127/328
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    Biomarker Research015.30
    Molecular Biomedicine09.10
    Cell Chemical Biology16612.60
    Molecular Oncology6311.40
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE08.70
    VIROLOGICA SINICA207.90
    Biotechnology Journal706.10
    Frontiers in Genetics616.20
    Advances in Biological Regulation05.30
    Pharmacogenomics & Personalized Medicine04.20
  • Journal for ImmunoTherapy of Cancer Journal for ImmunoTherapy of Cancer
    Predict CiteScore Trend：
    Steady Increase No Change Gradual Decline　 Refresh
 
    👁  148461 Views
    ☰  Reviews        
 
 
 

Select your rating and start your review of Journal for ImmunoTherapy of Cancer

 

    Journals In The Same Field
    CA-A CANCER JOURNAL FOR CLINICIANS
    CiteScore: 1154.20
    NATURE REVIEWS DRUG DISCOVERY
    CiteScore: 181.80
    MMWR Recommendations and Reports
    CiteScore: 129.90
    Nature Reviews Clinical Oncology
    CiteScore: 114.50
    Nature Reviews Disease Primers
    CiteScore: 113.30
    NATURE REVIEWS CANCER
    CiteScore: 103.80
    NEW ENGLAND JOURNAL OF MEDICINE
    CiteScore: 96.40
    LANCET
    CiteScore: 87.60
    NATURE REVIEWS IMMUNOLOGY
    CiteScore: 84.70
    NATURE MEDICINE
    CiteScore: 82.40



    © 2010-2026  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
    Privacy • Terms of Servic